Spyre Therapeutics, Inc.SYRENASDAQ
LOADING
|||
Gross Profit Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year gross profit growth rate
Latest
-100.00%
↓ 198% below average
Average (9y)
102.41%
Historical baseline
Range
High:1253.88%
Low:-100.00%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| 2024 | -100.00% |
| 2023 | -61.96% |
| 2022 | -87.57% |
| 2021 | 1253.88% |
| 2020 | -80.24% |
| 2019 | 0.00% |
| 2018 | 0.00% |
| 2017 | 0.00% |
| 2016 | 0.00% |
| 2015 | 100.00% |